Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaas Hoekman

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Direct activation of caspases by RGD-peptides may increase drug sensitivity of tumour cellsHenk J. Broxterman, Klaas Hoekman
International Journal of Cancer|September 10, 2005
Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategiesHester van Cruijsen, Giuseppe Giaccone, Klaas Hoekman
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 16, 2003
Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differencesHenk J Broxterman, Jan Lankelma, Klaas Hoekman
EXS|December 25, 2004
The hemostatic system in angiogenesisVictor W M van Hinsbergh, Pieter Koolwijk, Klaas Hoekman
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Tyrosine kinase inhibitors of VEGF receptors: clinical issues and remaining questionsHester van Cruijsen, Astrid van der Veldt, Klaas Hoekman
Drugs|July 31, 2003
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal managementCarla C P Verstappen, Jan J Heimans, Klaas Hoekman, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidineJeroen W J van Heijst, Hans W M Niessen, Klaas Hoekman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignanciesBart C Kuenen, Giuseppe Giaccone, Rita Ruijter, et al.
European Journal of Pharmacology|May 14, 2004
The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylaseMichiel De Bruin, Toni Van Capel, Kees Smid, et al.
Journal of Proteomics|December 4, 2008
Proteomics of the TRAP-induced platelet releasateSander R Piersma, Henk J Broxterman, Muhammed Kapci, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Direct activation of caspases by RGD-peptides may increase drug sensitivity of tumour cellsHenk J. Broxterman, Klaas Hoekman
International Journal of Cancer|September 10, 2005
Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategiesHester van Cruijsen, Giuseppe Giaccone, Klaas Hoekman
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 16, 2003
Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differencesHenk J Broxterman, Jan Lankelma, Klaas Hoekman
EXS|December 25, 2004
The hemostatic system in angiogenesisVictor W M van Hinsbergh, Pieter Koolwijk, Klaas Hoekman
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Tyrosine kinase inhibitors of VEGF receptors: clinical issues and remaining questionsHester van Cruijsen, Astrid van der Veldt, Klaas Hoekman
Drugs|July 31, 2003
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal managementCarla C P Verstappen, Jan J Heimans, Klaas Hoekman, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Advanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidineJeroen W J van Heijst, Hans W M Niessen, Klaas Hoekman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignanciesBart C Kuenen, Giuseppe Giaccone, Rita Ruijter, et al.
European Journal of Pharmacology|May 14, 2004
The effect of fluoropyrimidines with or without thymidine phosphorylase inhibitor on the expression of thymidine phosphorylaseMichiel De Bruin, Toni Van Capel, Kees Smid, et al.
Journal of Proteomics|December 4, 2008
Proteomics of the TRAP-induced platelet releasateSander R Piersma, Henk J Broxterman, Muhammed Kapci, et al.
Pageof 3